Percutaneous absorption of iodochlorhydroxyquin in humans.
Percutaneous absorption of iodochlorhydroxyquin in humans.
复制标题
碘氯羟喹在人体中的经皮吸收。
DOI:
10.1111/1523-1747.ep12259839
复制
发表时间:
1984
期刊:
影响因子:
--
通讯作者:
M. Makoid
中科院分区:
文献类型:
--
作者:
S. Stohs;F. W. Ezzedeen;A. Anderson;J. N. Baldwin;M. Makoid
Iodochlorhydroxyquin (I) is used in the treatment of diaper rash and other skin disorders, and is presumed to undergo little or no percutaneous absorption. The absorption of (I) from a 3% cream was studied in 5 normal male subjects after a single application of the cream for 12 h. Plasma levels of the drug were followed for 24 h after initial application while urinary excretion was measured for 54 h. (I) was extracted from plasma and urine and assayed by high-performance liquid chromatography. The drug in the range of 0.37-0.56 micrograms/ml was detected in plasma 2 h after application and persisted throughout the treatment period. The mean excretion rate after 12 h of application was 58.4 micrograms/h and the excretion rate was 8.8 micrograms/h at 42 h posttreatment. The elimination rate constant was calculated to be 0.15 h-1. Approximately 40% of the drug was absorbed over the 12-h application period. From the above results it is apparent that significant percutaneous absorption of (I) occurs.